157 results on '"Cappellesso R"'
Search Results
2. Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143)
- Author
-
Rastrelli, M., Del Fiore, P., Russo, I., Tartaglia, J., Dal Monico, A., Cappellesso, R., Nicole, L., Piccin, L., Fabozzi, A., Biffoli, B., Di Prata, C., Ferrazzi, B., Dall'Olmo, L., Vecchiato, A., Spina, R., Russano, F., Bezzon, E., Cingarlini, S., Mazzarotto, R., Parisi, A., Scarzello, G., Pigozzo, J., Brambullo, T., Tropea, S., Vindigni, V., Bassetto, F., Bertin, D., Gregianin, M., Dei Tos, A. P., Cavallin, F., Alaibac, M., Chiarion-Sileni, V., and Mocellin, S.
- Subjects
Cancer Research ,skin cancer ,Oncology ,Merkel treatment strategies ,Merkel carcinoma ,Merkel cell cancer ,non-melanoma skin cancer (NMSC) ,Original Research - Abstract
Background Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin. The incidence of the disease has undergone a significant increase in recent years, which is caused by an increase in the average age of the population and in the use of immunosuppressive therapies. MCC is an aggressive pathology, which metastasizes early to the lymph nodes. These characteristics impose an accurate diagnostic analysis of the regional lymph node district with radiography, clinical examination and sentinel node biopsy. In recent years, there has been a breakthrough in the treatment of the advanced pathology thanks to the introduction of monoclonal antibodies acting on the PD-1/PD-L1 axis. This study aimed to describe the clinico-pathological characteristics, treatment strategies and prognostic factors of MCC. Methods A retrospective cohort study was conducted involving 143 consecutive patients who were diagnosed and/or treated for MCC. These patients were referred to the Veneto Institute of Oncology IOV-IRCCS and to the University Hospital of Padua (a third-level center) in the period between December 1991 and January 2020. In the majority of cases, diagnosis took place at the IOV. However, some patients were diagnosed elsewhere and subsequently referred to the IOV for a review of the diagnosis or to begin specific therapeutic regimens. Results 143 patients, with an average age of 71 years, were affected mainly with autoimmune and neoplastic comorbidities. Our analysis has shown that age, autoimmune comorbidities and the use of therapy with immunomodulating drugs (which include corticosteroids, statins and beta-blockers) are associated with a negative prognosis. In this sense, male sex is also a negative prognostic factor. Conclusions Autoimmune and neoplastic comorbidities were frequent in the studied population. The use of drugs with immunomodulatory effects was also found to be a common feature of the population under examination. The use of this type of medication is considered a negative prognostic factor. The relevance of a multidisciplinary approach to the patient with MCC is confirmed, with the aim of assessing the risks and benefits related to the use of immunomodulating therapy in the individual patient.
- Published
- 2021
- Full Text
- View/download PDF
3. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
- Author
-
El Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D., Amendola, L. C., Gharib, M., Kallala, A., Arun, I., Azmoudeh-Ardalan, F., Fujimoto, L., Sua, L. F., Liu, S. -W., Lien, H. -C., Kirtani, P., Balancin, M., El Attar, H., Guleria, P., Yang, W., Shash, E., Chen, I. -C., Bautista, V., Do Prado Moura, J. F., Rapoport, B. L., Castaneda, C., Spengler, E., Acosta-Haab, G., Frahm, I., Sanchez, J., Castillo, M., Bouchmaa, N., Md Zin, R. R., Shui, R., Onyuma, T., Husain, Z., Willard-Gallo, K., Coosemans, A., Perez, E. A., Provenzano, E., Ericsson, P. G., Richardet, E., Mehrotra, R., Sarancone, S., Ehinger, A., Rimm, D. L., Bartlett, J. M. S., Viale, G., Denkert, C., Hida, A. I., Sotiriou, C., Loibl, S., Hewitt, S. M., Badve, S., Symmans, W. F., Kim, R. S., Pruneri, G., Goel, S., Francis, P. A., Inurrigarro, G., Yamaguchi, R., Garcia-Rivello, H., Horlings, H., Afqir, S., Salgado, R., Adams, S., Kok, M., Dieci, M. V., Michiels, S., Demaria, S., Loi, S., Schelfhout, V., Arbzadeh, E., Bondanar, A., Reyes, S. A. G., Ruz, J. R., Kang, J., Xiang, L., Zimovjanova, M., Togores, P., Ozturk, T., Patil, A., Corpa, M., Whitehouse, A., Tan, B., de Paula, A., Rossetti, C., Lang-Schwarz, C., Mahon, S., Giacometti, C., Linderholm, B., Deman, F., Montagna, G., Gong, G., Pavcovich, M., Chaer, Y., Cabrero, I. A., de Brito, M. L., Ilieva, N., Fulop, A., Souza, M., Bilancia, D., Idowu, M., Johri, R., Szpor, J., Bachani, L., Schmitt, F., Giannotti, M., Kurebayashi, Y., Ramirez, B. E. A., Salido, E., Bortesi, L., Bonetto, S., Elomina, K., Lopez, P., Sharma, V., Edirisinghe, A., Mathur, D., Sahay, A., Mouloud, M. A., Giang, C. H., Mukolwe, E., Kiruka, E., Samberg, N., Abe, N., Brown, M., Millar, E., X. B., Li, Yuan, Z., Pasupathy, A., Miele, R., Luff, R., e Porfirio, M. M. A., Ajemba, O., Soni, R., Orvieto, E., Dimaio, M., Thomas, J., Merard, R., Subramaniam, M. M., Apolinario, T., Preda, O., Preda, R., Makanga, A., Maior, M. S., Li, L., Saghatchian, M., Saurine, T., Janssen, E., Cochran, J., Vlada, N., Cappellesso, R., Elfer, K., Hollick, M., Desai, S., Oner, G., Schreurs, A., Liu, S., Perera, R., Mercurio, P., Garcia, F., Hosny, K., Matsumoto, H., van Deurzen, C., Bianchini, G., Coban, I., Jahangir, A., Rahman, A., Stover, D., Luz, P., Martel, A., Waumans, Y., Stenzinger, A., Cortes, J., Dimitrova, P., Nauwelaers, I., Velasco, M., Fan, F., Akturk, G., Firer, M., Roxanis, I., Schneck, M., Wen, H., Cockenpot, V., Konstantinov, A., Calatrava, A., Vidya, M. N., Choi, H. J., Jank, P., Ciinen, A. H., Sabanathan, D., Floris, G., Hoeflmayer, D., Hamada, T., Laudus, N., Grigoriadis, A., Porcellato, I., Acs, B., Miglietta, F., Parrodi, J., Clunie, D., Calhoun, B., F. -I., Lu, Lefevre, A., Tabbarah, S., Tran, W., Garcia-murillas, I., Jelinic, P., Boeckx, C., Souza, S., Cebollero, M. C., Felip, E., Rendon, J. L. S., El Gabry, E., Saltz, J., Bria, E., Garufi, G., Hartman, J., Sebastian, M., Olofsson, H., Kooreman, L., Cucherousset, J., Mathieu, M. -C., Ballesteros-Merino, C., Siziopikou, P., Fong, J., Klein, M., Qulis, I. R. I., Wesseling, J., Bellolio, E., Araya, J. C., Naber, S., Cheang, M., Castellano, I., Ales, A., Laenkholm, A. -V., Kulka, J., Quinn, C., Sapino, A., Amendoeira, I., Marchio, C., Braybrooke, J., Vincent-Salomon, A., Korski, K. P., Sofopoulos, M., Stovgaard, E. I. S., Bianchi, S., Bago-Horvath, Z., Yu, C., Regitnig, P., Hall, S., Kos, Z., Sant, S., Tille, J. -C., Gallas, B., Bethmann, D., Savas, P., Mendes, L., Soler, T., van Seijen, M., Gruosso, T., Quintana, A., Giltnane, J., Van den Eynden, G., Duregon, E., de Cabo, R., Recamo, P. C., Gaboury, L., Zimmerman, J., Pop, C. S., Wernicke, A., Williams, D., Gill, A., Solomon, B., Thapa, B., Farshid, G., Gilham, L., Christie, M., O'Toole, S., Hendry, S., Fox, S. B., Luen, S. J., Lakhani, S. R., Fuchs, T., John, T., Brcic, I., Hainfellner, J., Sigurd, L., Preusser, M., Poortmans, P., Decaluwe, A., Carey, C., Colpaert, C., Larsimont, D., Peeters, D., Broeckx, G., van de Vijver, K., Buisseret, L., Dirix, L., Hertoghs, M., Piccart, M., Ignatiadis, M., Van Bockstal, M., Sirtaine, N., Vermeulen, P., de Wind, R., Declercq, S., Gevaert, T., Haibe-Kans, B., Nelson, B. H., Watson, P. H., Leung, S., Nielsen, T., Shi, L., Balslev, E., Thagaard, J., Almangush, A., Makitie, A., Joensuu, H., Lundin, J., Drubay, D., Roblin, E., Andre, F., Penault-Llorca, F., Lemonnier, J., Adam, J., Lacroix-Triki, M., Ternes, N., Radosevic-Robin, N., Klaushen, F., Weber, K., Harbeck, N., Gluz, O., Wienert, S., Cserni, G., Vingiani, A., Criscitiello, C., Solinas, C., Curigliano, G., Konishi, E., Suzuki, E., Yoshikawa, K., Kawaguchi, K., Takada, M., Toi, M., Ishida, M., Shibata, N., Saji, S., Kogawa, T., Sakatani, T., Okamoto, T., Moriya, T., Kataoka, T., Shimoi, T., Sugie, T., Mukohara, T., Shu, Y., Kikawa, Y., Kozuka, Y., Sayed, S., Rahayu, R., Ramsaroop, R., Senkus-Konefka, E., Chmielik, E., Cardoso, F., Ribeiro, J., Chan, J., Dent, R., Martin, M., Hagen, C., Guerrero, A., Rojo, F., Comerma, L., Nuciforo, P., Serrano, V. V., Camaea, V. P., Steenbruggen, T., Ciompi, F., Nederlof, I., Jan, Hudecek, van der Laak, J., van den Berg, J., Voorwerk, L., van de Vijver, M., de Maaker, M., Linn, S., Mckenzie, H., Somaiah, N., Tutt, A., Swanton, C., Hiley, C., Moore, D. A., Hall, J. A., Le Quesne, J., Jabbar, K. A., al Bakir, M., Hills, R., Irshad, S., Yuan, Y., Li, Z., Liu, M., Klein, J., Fadare, O., Thompson, A., Lazar, A. J., Gown, A., Lo, A., Garrido Castro, A. C., Madabhushi, A., Moreira, A., Richardson, A., Beck, A. H., Bellizzi, A. M., Wolff, A., Harbhajanka, A., Sharma, A., Cimino-Mathews, A., Srinivasan, A., Singh, B., Chennubhotla, C. S., Chauhan, C., Dillon, D. A., Zardavas, D., Johnson, D. B., Thompson, A. E., Brogi, E., Reisenbichler, E., Huang, E., Hirsch, F. R., Mcarthur, H., Ziai, J., Brock, J., Kerner, J., Zha, J., Lennerz, J. K., Carter, J. M., Reis-Filho, J., Sparano, J., Balko, J. M., Pogue-Geile, K., Steele, K. E., Blenman, K. R. M., Allison, K. H., Pusztai, L., Cooper, L., Estrada, V. M., Flowers, M., Robson, M., Rebelatto, M. C., Hanna, M. G., Goetz, M. P., Khojasteh, M., Sanders, M. E., Regan, M. M., Misialek, M., Amgad, M., Tung, N., Singh, R., Huang, R., Pierce, R. H., Leon-Ferre, R., Swain, S., Ely, S., Kim, S. -R., Bedri, S., Paik, S., Schnitt, S., D'Alfons, T., Kurkure, U., Bossuyt, V., Tong, W., Wang, Y., Dos Anjos, C. H., Gaire, F., Van Diest, P. J., El Bairi, Khalid [0000-0002-8414-4145], de Freitas, Juliana Ribeiro [0000-0003-4978-7273], Sur, Daniel [0000-0002-0926-4614], Amendola, Luis Claudio [0000-0002-6404-450X], Azmoudeh-Ardalan, Farid [0000-0003-4701-0532], Kirtani, Pawan [0000-0002-2343-7016], Yang, Wenxian [0000-0002-5349-9680], Castillo, Miluska [0000-0002-0111-3176], Provenzano, Elena [0000-0003-3345-3965], Mehrotra, Ravi [0000-0001-9453-1408], Ehinger, Anna [0000-0001-9225-7396], Rimm, David L [0000-0001-5820-4397], Bartlett, John MS [0000-0002-0347-3888], Denkert, Carsten [0000-0002-2249-0982], Hida, Akira I [0000-0002-4486-8819], Sotiriou, Christos [0000-0002-5745-9977], Hewitt, Stephen M [0000-0001-8283-1788], Badve, Sunil [0000-0001-8861-9980], Symmans, William Fraser [0000-0002-1526-184X], Goel, Shom [0000-0001-8329-9084], Francis, Prudence A [0000-0002-7207-9286], Horlings, Hugo [0000-0003-4782-8828], Salgado, Roberto [0000-0002-1110-3801], Demaria, Sandra [0000-0003-4426-0499], Loi, Sherene [0000-0001-6137-9171], Apollo - University of Cambridge Repository, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'anatomie pathologique, Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), and UNICANCER
- Subjects
Oncology ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,TRASTUZUMAB ,Improved survival ,MICROENVIRONMENT ,Review Article ,SUBTYPES ,NEOADJUVANT CHEMOTHERAPY ,0302 clinical medicine ,Breast cancer ,Ecology,Evolution & Ethology ,PROGNOSTIC-SIGNIFICANCE ,Medicine and Health Sciences ,Pharmacology (medical) ,TUMOR-INFILTRATING LYMPHOCYTES ,Stage (cooking) ,RC254-282 ,Chemical Biology & High Throughput ,0303 health sciences ,Human Biology & Physiology ,Genome Integrity & Repair ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,ASSOCIATION ,3. Good health ,030220 oncology & carcinogenesis ,Biomarker (medicine) ,Life Sciences & Biomedicine ,Genetics & Genomics ,medicine.medical_specialty ,chemical and pharmacologic phenomena ,International Immuno-Oncology Biomarker Working Group ,Predictive markers ,03 medical and health sciences ,Signalling & Oncogenes ,SDG 3 - Good Health and Well-being ,Internal medicine ,692/53/2423 ,medicine ,Radiology, Nuclear Medicine and imaging ,In patient ,030304 developmental biology ,Computational & Systems Biology ,Science & Technology ,IDENTIFICATION ,business.industry ,review-article ,Cancer ,03.01. Általános orvostudomány ,Immunotherapy ,Tumour Biology ,medicine.disease ,PREDICTIVE-VALUE ,692/4028/67/1347 ,Programmed death 1 ,business ,FREE SURVIVAL - Abstract
The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potentially benefit from ICI targeting the programmed death 1 (PD-1)/PD-L1 signaling axis. The use of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarkers has been under intense examination. Emerging data suggest that TILs are associated with response to both cytotoxic treatments and immunotherapy, particularly for patients with triple-negative BC. In this review from The International Immuno-Oncology Biomarker Working Group, we discuss (a) the biological understanding of TILs, (b) their analytical and clinical validity and efforts toward the clinical utility in BC, and (c) the current status of PD-L1 and TIL testing across different continents, including experiences from low-to-middle-income countries, incorporating also the view of a patient advocate. This information will help set the stage for future approaches to optimize the understanding and clinical utilization of TIL analysis in patients with BC. ispartof: NPJ BREAST CANCER vol:7 issue:1 ispartof: location:United States status: published
- Published
- 2021
4. β-Arrestin-1 expression and epithelial-to-mesenchymal transition in laryngeal carcinoma
- Author
-
Marioni, G, Nicolè, L, Cappellesso, R, Marchese-Ragona, R, Fasanaro, E, Di Carlo, R, La Torre FB, Nardello, E, Sanavia, T, Ottaviano, G, Fassina, A, and MARCHESE RAGONA, Rosario
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Epithelial-Mesenchymal Transition ,Clinical Biochemistry ,Pathology and Forensic Medicine ,Nicotine ,03 medical and health sciences ,0302 clinical medicine ,Antigens, CD ,Internal medicine ,Biomarkers, Tumor ,Carcinoma ,Humans ,Medicine ,Epithelial–mesenchymal transition ,Laryngeal Neoplasms ,Pathological ,Aged ,Zinc Finger E-box Binding Homeobox 2 ,business.industry ,Zinc Finger E-box-Binding Homeobox 1 ,Cancer ,Middle Aged ,Cadherins ,Prognosis ,medicine.disease ,Survival Rate ,beta-Arrestin 1 ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cohort ,Carcinoma, Squamous Cell ,β arrestin 1 ,Female ,β-Arrestin-1 expression and epithelial-to-mesenchymal transition in laryngeal carcinoma ,Signal transduction ,business ,Follow-Up Studies ,medicine.drug - Abstract
Aim: The novel primary end-point of the present study was to ascertain β-arrestin-1 expression in a cohort of consecutive patients with laryngeal squamous cell carcinoma (LSCC) with information available on their cigarette-smoking habits. A secondary end-point was to conduct a preliminary clinical and pathological investigation into the possible role of β-arrestin-1 in the epithelial-to-mesenchymal transition (EMT), identified by testing for E-cadherin, Zeb1, and Zeb2 expression, in the setting of LSCC. Methods: The expression of β-arrestin-1, E-cadherin, zeb1, and zeb2 was ascertained in 20 consecutive LSCCs. Results: Statistical analysis showed no significant associations between β-arrestin-1 and EMT (based on the expression of E-cadherin, Zeb1, and Zeb2). The combined effect of nicotine and β-arrestin-1 was significantly associated with a shorter disease-free survival ( P=0.01) in our series of LSCC. This latter result was also confirmed in an independent, publicly available LSCC cohort ( P=0.047). Conclusions: Further investigations on larger series (ideally in prospective settings) are needed before we can consider closer follow-up protocols and/or more aggressive treatments for patients with LSCC and a combination of nicotine exposure and β-arrestin-1 positivity in tumor cells at the time of their diagnosis. Further studies on how β-arrestin functions in cancer via different signaling pathways might reveal potential targets for the treatment of even advanced laryngeal malignancies.
- Published
- 2019
5. MIR-21/MIR-126 EXPRESSION ANALYSIS: A NEW HELPFUL TOOL IN THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA: FP7-3
- Author
-
Cappellesso, R., Nicolè, L., Guzzardo, V., Ventura, L., and Fassina, A.
- Published
- 2015
6. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI)
- Author
-
Elefanti, L., Zamuner, C., Del Fiore, P., Stagni, C., Pellegrini, S., Dall'Olmo, L., Fabozzi, A., Senetta, R., Ribero, S., Salmaso, R., Mocellin, S., Bassetto, F., Cavallin, F., Tosi, A. L., Galuppini, F., Dei Tos, A. P., Menin, C., and Cappellesso, R.
- Subjects
Male ,Skin Neoplasms ,DNA Copy Number Variations ,NRAS ,Polymorphism, Single Nucleotide ,Article ,Acral melanoma ,ARID1A ,BRAF ,Copy number variations ,KIT ,PREX2 ,TERT promoter ,TP53 ,lcsh:Chemistry ,Aged ,Aged, 80 and over ,Female ,Humans ,Italy ,Melanoma ,Middle Aged ,Mutation ,Neoplasm Grading ,Neoplasm Staging ,Prognosis ,Biomarkers, Tumor ,Disease Susceptibility ,80 and over ,Polymorphism ,lcsh:QH301-705.5 ,Tumor ,Single Nucleotide ,acral melanoma ,copy number variations ,lcsh:Biology (General) ,lcsh:QD1-999 ,Biomarkers - Abstract
Acral melanoma (AM) is a rare and aggressive subtype of melanoma affecting the palms, soles, and nail apparatus with similar incidence among different ethnicities. AM is unrelated to ultraviolet radiation and has a low mutation burden but frequent chromosomal rearrangements and gene amplifications. Next generation sequencing of 33 genes and somatic copy number variation (CNV) analysis with genome-wide single nucleotide polymorphism arrays were performed in order to molecularly characterize 48 primary AMs of Italian patients in association with clinicopathological and prognostic features. BRAF was the most commonly mutated gene, followed by NRAS and TP53, whereas TERT promoter, KIT, and ARID1A were less frequently mutated. Gains and losses were recurrently found in the 1q, 6p, 7, 8q, 20 and 22 chromosomes involving PREX2, RAC1, KMT2C, BRAF, CCND1, TERT, and AKT3 genes, and in the 6q, 9, 10, 11q and 16q chromosomes including CDKN2A, PTEN, and ADAMTS18 genes, respectively. This study confirmed the variety of gene mutations and the high load of CNV in primary AM. Some genomic alterations were associated with histologic prognostic features. BRAF mutations, found with a higher rate than previously reported, correlated with a low Breslow thickness, low mitotic count, low CNV of the AMs, and with early-stage of disease.
- Published
- 2021
7. Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study (Front. Oncol, (2021), 11, (725523), 10.3389/fonc.2021.725523)
- Author
-
Del Fiore, P., Russo, I., Ferrazzi, B., Monico, A. D., Cavallin, F., Filoni, A., Tropea, S., Russano, F., Di Prata, C., Buja, A., Collodetto, A., Spina, R., Carraro, S., Cappellesso, R., Nicole, L., Chiarion-Sileni, V., Pigozzo, J., Dall'Olmo, L., Rastrelli, M., Vecchiato, A., Benna, C., Menin, C., Di Carlo, D., Bisogno, G., Dei Tos, A. P., Alaibac, M., and Mocellin, S.
- Subjects
skin cancer ,AYA ,incidence ,melanoma ,adolescent and young adult melanoma ,melanoma surgical treatment ,adolescent and young adult oncology ,survival - Published
- 2021
8. Cytopathological findings in a siderotic liver nodule
- Author
-
Cappellesso, R., Bombonato, M., Fabbro, M., Zanus, G., and Fassina, A.
- Published
- 2013
- Full Text
- View/download PDF
9. Fine needle aspiration of non-small cell lung cancer: current state and future perspective
- Author
-
Fassina, A., Cappellesso, R., Simonato, F., Lanza, C., Marzari, A., and Fassan, M.
- Published
- 2012
- Full Text
- View/download PDF
10. Autoimmune gastritis: histology phenotype and OLGA staging
- Author
-
Rugge, M., Fassan, M., Pizzi, M., Zorzetto, V., Maddalo, G., Realdon, S., De Bernard, M., Betterle, C., Cappellesso, R., Pennelli, G., de Boni, M., and Farinati, F.
- Published
- 2012
- Full Text
- View/download PDF
11. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules
- Author
-
Fassina, A., Corradin, M., Zardo, D., Cappellesso, R., Corbetti, F., and Fassan, M.
- Published
- 2011
- Full Text
- View/download PDF
12. Seeding of tumour cells after fine needle aspiration cytology in liver nodules: myth or reality?
- Author
-
Fassina, A., Fabbro, M., Cappellesso, R., and Fassan, M.
- Published
- 2010
- Full Text
- View/download PDF
13. Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma
- Author
-
Piano, M. A., Brunello, A., Cappellesso, R., Bianco, P. D., Mattiolo, A., Fritegotto, C., Montini, B., Zamuner, C., Fiore, P. D., Rastrelli, M., Sommariva, A., de Salvo, G. L., Montesco, M. C., Rossi, C. R., Zagonel, V., and Calabro, M. L.
- Subjects
Leiomyosarcoma ,Male ,Epithelial-Mesenchymal Transition ,Fibrosarcoma ,Pilot Projects ,Soft Tissue Neoplasms ,Prognosis ,Gene Expression Regulation, Neoplastic ,Survival Rate ,Tissue Array Analysis ,Biomarkers, Tumor ,Humans ,Female ,Prospective Studies ,Cell Adhesion Molecules ,Aged ,Follow-Up Studies ,Retrospective Studies - Abstract
Interpatient clinical variability in soft-tissue sarcomas (STS) highlights the need for novel prognostic markers supporting patient risk stratification. As sarcomas might exhibit a more mesenchymal or a more epithelial state, we focused on epithelial-mesenchymal and mesenchymal-epithelial transitions (EMT/MET) for prognostic clues, and selected three histotypes with variable aggressiveness.The expression of EMT/MET-related factors was measured by qRT-PCR in 55 tumor samples from patients with leiomyosarcoma, myxofibrosarcoma, or undifferentiated pleomorphic sarcoma. The identified marker was further evaluated by IHC in 31 leiomyosarcomas and by measuring its circulating levels in 67 patients. The prognostic value of a sarcoma-tailored EMT score was analyzed. Epirubicin chemosensitivity and migration were studied in primary STS cultures. Associations with overall survival (OS) were assessed using Kaplan-Meier and Cox regression methods.High expression of periostin, a mesenchymal matricellular protein, in sarcoma tissues (Although limited to a pilot study, these findings suggest that periostin might contribute prognostic information in the three studied STS histotypes. Moreover, a transitioning EMT score measured in the tumor might predict a less active and a more chemosensitive disease.
- Published
- 2019
14. Diagnostic accuracy of an immunohistochemical panel to distinguish intrahepatic cholangiocarcinoma from bile duct adenoma
- Author
-
Nicole, L., Sarcognato, S., Cappellesso, R., Tiziana Sanavia, Luchini, C., Mescoli, C., Capelli, P., Fassina, A., and Guido, M.
- Published
- 2019
15. Calcific myonecrosis of the leg: A rare entity
- Author
-
Angelini, A. Mavrogenis, A.F. Pagliarini, E. Trovarelli, G. Fanelli, G.N. Cappellesso, R. Ruggieri, P.
- Abstract
Calcific myonecrosis is a rare disease that has been shown to be a late sequela of trauma. This article presents a 68-year-old man with calcific myonecrosis of the leg 40 years after a tibial fracture complicated with peroneal nerve palsy. The soft tissue mass increased in size after another injury to the leg that occurred two years before his presentation. Physical examination at presentation showed a palpable extra-osseous mass at the anterior aspect of the left leg; the mass was not adherent to adjacent soft-tissues and bone, and it was painless but tender to palpation. Radiographs of the left leg showed extensive calcification at the soft-tissue of the anterior and posterior leg. An ultrasonography-guided trocar biopsy was done; histological findings were indicative of calcific myonecrosis. Given the benign entity of the lesion and known high rate of complications, he was recommended for no further treatment except for clinical and imaging observation. Located at the site of the biopsy, he experienced infection with drainage that eventually healed after six months with antibiotics and wound dressing changes. During the last follow-up examination, two years after diagnosis, the patient was asymptomatic without progression of the mass. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
- Published
- 2019
16. No differences in nasal tissue inflammatory cells and adhesion molecules (iCAM-1 and vCAM-1) comparing EGPA with eosinophilic chronic sinusitis with polyposis
- Author
-
Brescia, G, Schiavon, F, Nicolè, L, Zanoletti, E, Zanotti, C, Padoan, R, Felicetti, M, Parrino, D, Cinetto, F, Cangiano, D, Giacomelli, L, Cappellesso, R, Martini, A, Fassina, A, and Marioni, G.
- Published
- 2019
17. Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (Cancer Cell International (2018) 18 (131) DOI: 10.1186/s12935-018-0634-8)
- Author
-
Fassan, M., Vianello, L., Sacchi, D., Fanelli, G. N., Munari, G., Scarpa, M., Cappellesso, R., Loupakis, F., Lanza, C., Salmaso, R., Mescoli, C., Valeri, N., Agostini, M., D'Angelo, E., Lonardi, S., Pucciarelli, S., Veronese, N., Luchini, C., and Rugge, M.
- Published
- 2019
18. Myoepithelial carcinoma of mixed cell type: a rare entity
- Author
-
Erica Dalla Venezia, Brambullo T, Kohlscheen E, Salmaso R, Cappellesso R, De Antoni E, Dalla Venezia E, Vindigni V, and Bassetto F
- Subjects
Pathology ,medicine.medical_specialty ,Mesenchymal stem cell ,Myoepithelial cell ,Myoepithelial Carcinoma ,Rare entity ,Mixed cell ,Biology ,medicine.disease ,stomatognathic diseases ,medicine ,Carcinoma ,Pediatric dermatology ,Large group - Abstract
Myoepitheliomas represent a large group of uncommon mesenchymal neoplasms characterized by myoepithelial differentiation.
- Published
- 2018
19. Transcriptomics landscape of Necroptosis genes is associated with Dendritic cells infiltration: a pan-cancer study of 5,451 primary solid tumors
- Author
-
Nicolè, L, Sanavia, T, Cappellesso, R, and Fassina, A
- Published
- 2018
20. Evaluation of necroptosis related genes RIPK1, RIPK3 and MLKL-p immunogenicity in hepatocellular carcinoma
- Author
-
Nicole, L., Tiziana Sanavia, Cappellesso, R., Maffeis, V., Guzzardo, V., Radu, C. M., Guido, M., Zanus, G., and Fassina, A.
- Published
- 2018
21. Immunohistochemical and HPV-related features of laryngeal adenosquamous carcinoma
- Author
-
Lovato, A, Staffieri, Alberto, Marino, F, Cappellesso, R, Barzon, Luisa, Marchese Ragona, R, Ottaviano, Giancarlo, Marioni, Gino, and MARCHESE RAGONA, Rosario
- Subjects
Male ,Oncology ,medicine.medical_specialty ,Pathology ,business.industry ,Adenosquamous carcinoma ,HPV infection ,Histology ,Middle Aged ,medicine.disease ,Malignancy ,Carcinoma, Adenosquamous ,medicine.anatomical_structure ,Otorhinolaryngology ,Internal medicine ,Humans ,Medicine ,Adenocarcinoma ,Radical surgery ,business ,Laryngeal Neoplasms ,Papillomaviridae ,Lymph node ,Laryngeal Adenosquamous Carcinoma - Abstract
Background Adenosquamous carcinoma (ASC) of the head and neck is a rare malignancy characterized by loco-regional and distant aggressiveness. At histology, ASC reveals two distinct, juxtaposed components, squamous cell carcinoma (SCC), and true adenocarcinoma. Methods The immunohistochemical expression of AE3, CK19 and CAM5.2, and HPV infection was tested in a case of laryngeal ASC. Results The patient had no regional lymph node metastases, but developed a recurrence in neck soft tissues shortly after primary radical surgery. The laryngeal surgical specimen had the typical morphological features of ASC. The tumor's squamous and glandular components were both strongly and diffusely immunoreactive for AE3 and CK19, whereas CAM5.2 selectively stained only the gland-like part. We found no high- or low-risk HPV DNA (28 genotypes) in the specimens. The patient underwent salvage extended radical neck dissection and received postoperative radio-chemotherapy. At 4-month follow-up control, neck recurrence was found. Palliative chemotherapy was instituted. Conclusions An accurate histological and immunohistochemical diagnosis is mandatory to differentiate ASC from conventional SCC. Radical surgical excision is recommended for laryngeal ASC. Adjuvant postoperative therapy is administered in most cases, but there are no widely accepted indications for these treatments.
- Published
- 2015
22. Immunogenic role of Necrosis-inducing complex RIPK1-RIPK3-MLKL-P in Hepatocellular Carcinoma
- Author
-
Nicolè, L, Sanavia, T, Maffeis, V, Cappellesso, R, Salizzato, K, Pegoraro, M, Zorzi, S, Guzzardo, V, Maria, G, Zanus, G, and Fassina, A
- Published
- 2017
23. Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype
- Author
-
Dieci, MV, primary, Giaratano, T, additional, Miglietta, F, additional, Griguolo, G, additional, Orvieto, E, additional, Falci, C, additional, Giorgi, CA, additional, Mioranza, E, additional, Tasca, G, additional, Cappellesso, R, additional, Ghiotto, C, additional, Conte, P, additional, and Guarneri, V, additional
- Published
- 2017
- Full Text
- View/download PDF
24. L’espressione di endoglina (CD105) nella poliposi rinosinusale
- Author
-
Favaretto, N., Marioni, G., Cappellesso, R., Mylonakis, I., Lionello, M., Marchese-Ragona, R, Marino, F., Staffieri, A., Martini, A., and Ottaviano, G.
- Published
- 2015
25. l'espressione di endoglina (CD 105) nella poliposi nasosinusale
- Author
-
Favaretto, N, Marioni, G, Cappellesso, R, Milonakys, I, Lionello, M, Marchese-Ragona, R, Marino, F, Staffieri, A, Martini, A, and Ottaviano, G.
- Published
- 2015
26. P.13.11 KAPLAN-MEIER CUMULATIVE SURVIVAL CURVES: A SIX YEAR EXPERIENCE OF A LARGE VOLUME COLONOSCOPY COLORECTAL CANCER SCREENING CENTER
- Author
-
Pontarolo, N., primary, Merlo, F., additional, Rosa-rizzotto, E., additional, Guido, E., additional, Caroli, D., additional, Lomele, M., additional, Cappellesso, R., additional, Rugge, M., additional, Mammano, E., additional, Pilati, P., additional, and De Lazzari, F., additional
- Published
- 2016
- Full Text
- View/download PDF
27. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears
- Author
-
Fassina, Ambrogio, Cappellesso, R, Simonato, F, Maayan, S, Ventura, L, Tosato, F, Bisund, Lt, Pelizzo, Mr, and Fassan, M.
- Subjects
Male ,Lymphoma ,Biopsy, Fine-Needle ,Real-Time Polymerase Chain Reaction ,Thyroid Carcinoma, Anaplastic ,Mantel zone lymphoma ,Thyroid cancer ,Cohort Studies ,Diagnosis, Differential ,Rare Diseases ,Humans ,Thyroid Neoplasms ,Fine-needle cytology ,MicroRNAs ,Primary thyroid lymphoma ,Aged ,Retrospective Studies ,Aged, 80 and over ,Middle Aged ,Flow Cytometry ,Immunohistochemistry ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,ROC Curve ,Female ,Goiter, Nodular - Abstract
Anaplastic thyroid carcinoma (ATC) and primary thyroid lymphoma (PTL) are uncommon tumors of the thyroid gland with several overlapping clinical and pathologic features that may render their differentiation difficult in fine-needle aspiration (FNA) cytology. MicroRNA (miRNA) signatures have been recently reported as useful diagnostic tools applied to cytology specimens.Smears of 23 ATCs, 14 PTLs, and 20 non-neoplastic materials with multinodular goiter (MNG) were retrieved and classified based on their cytologic features and flow cytometric profiles. The ATC-related expression of hsa-miR-26a, hsa-miR-146b, hsa-miR-221, and hsa-miR-222 was quantified using quantitative reverse transcriptase-polymerase chain reaction analysis.All miRNAs were remarkably up-regulated in ATC samples compared with PTL samples (P .01). Moreover, expression levels of hsa-miR-146b, hsa-miR-221, and hsa-miR-222 were significantly higher in ATCs than in MNG samples (P .01). Significant down-regulation of hsa-miR-26a was observed in PTLs compared with MNG samples, whereas hsa-miR-146b was overexpressed. Receiver operating characteristic analysis was used to determine the optimal cutoff for distinguishing ATC from PTL. The estimated receiver operating characteristic thresholds displayed a sensitivity level greater than 0.80 in achieving a diagnosis of PTL, allowing the correct identification of 13 of 14 PTL samples (93%).Histotype-specific miRNA signatures can provide new insight into the molecular mechanisms of thyroid carcinogenesis. The tested 4-miRNA signature is a promising diagnostic tool for differentiating ATC from PTL and non-neoplastic MNG, even in the presence of scant material obtained from minimally invasive procedures.
- Published
- 2013
28. Anaplastic thyroid carcinoma and primary thyroid lymphoma: The role of miRNA
- Author
-
Fassina, A[ 1 ], Simonato, F, Siri, M, Cappellesso, R, Marino, F, Crescenzi, Marika, Pivato, M, Pellizzo, Mr, Fassan, M., and Ventura, L
- Published
- 2013
29. The diagnostic value of miR17-92 microRNA cluster in diffuse large B-cell lymphoma
- Author
-
Fassina, A[ 1 ], Cappellesso, R, Marino, F, Siri, M, Simonato, F, Benetti, M, Crescenzi, Marika, Trento, M, Ventura, L, and Fassan, M.
- Published
- 2013
30. Spaceflight osteoporosis: current state and future perspective
- Author
-
Cappellesso, R., primary, Nicole, L., additional, Guido, A., additional, and Pizzol, D., additional
- Published
- 2015
- Full Text
- View/download PDF
31. OC.05.5 CANCER INVADING THE SUBMUCOSAL LAYER: IS IT TIME TO CHANGE SURGICAL INDICATIONS FOR SCREENING COLONOSCOPIES?
- Author
-
Rosa-Rizzotto, E., primary, Lo Mele, M., additional, Caroli, D., additional, Guido, E., additional, Ancona, F., additional, Peraro, L., additional, Cappellesso, R., additional, Cocchio, S., additional, Baldo, V., additional, Rugge, M., additional, and De Lazzari, F., additional
- Published
- 2013
- Full Text
- View/download PDF
32. Cytopathological findings in a siderotic liver nodule
- Author
-
Cappellesso, R., primary, Bombonato, M., additional, Fabbro, M., additional, Zanus, G., additional, and Fassina, A., additional
- Published
- 2011
- Full Text
- View/download PDF
33. MicroRNA analysis as a potential diagnostic tool in the cytological diagnosis of non-small cell lung cancer.
- Author
-
Fassina, A., primary, Cappellesso, R., additional, Olivotto, A., additional, and Fassan, M., additional
- Published
- 2011
- Full Text
- View/download PDF
34. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules
- Author
-
Fassina, A., primary, Corradin, M., additional, Zardo, D., additional, Cappellesso, R., additional, Corbetti, F., additional, and Fassan, M., additional
- Published
- 2010
- Full Text
- View/download PDF
35. Genome instability in metachronous esophageal cancer
- Author
-
Boldrin, E., Rumiato, E., Chiarion-Sileni, V., Rugge, M., Cappellesso, R., Cagol, M., Ruol, A., Rita Alfieri, Amadori, A., and Saggioro, D.
36. SDHB expression in paraganglioma-pheochromocytoma syndromes: advantages and limits
- Author
-
Fassina, A., Tricarico, P., Schiavi, F., Guzzardo, V., Cappellesso, R., Bombonato, M., Giuseppe Opocher, and Fassan, M.
37. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
- Author
-
Edoardo D'Angelo, Fotios Loupakis, Giuseppe Nicolò Fanelli, Giada Munari, Nicola Veronese, Diana Sacchi, Claudia Mescoli, Matteo Fassan, Sara Lonardi, Massimo Rugge, Luca Vianello, Salvatore Pucciarelli, Marco Agostini, Nicola Valeri, Marco Scarpa, Cristiano Lanza, Claudio Luchini, Rocco Cappellesso, Roberta Salmaso, Fassan, M., Vianello, L., Sacchi, D., Fanelli, G.N., Munari, G., Scarpa, M., Cappellesso, R., Loupakis, F., Lanza, C., Salmaso, R., Mescoli, C., Valeri, N., Agostini, M., D'Angelo, E., Lonardi, S., Pucciarelli, S., Veronese, N., Luchini, C., and Rugge, M.
- Subjects
0301 basic medicine ,Neuroblastoma RAS viral oncogene homolog ,Cancer Research ,Colorectal cancer ,Biomarkers ,Extranodal extension ,Metastasis ,Oncology ,Genetics ,PDGFRA ,medicine.disease_cause ,lcsh:RC254-282 ,not known ,03 medical and health sciences ,0302 clinical medicine ,medicine ,PTEN ,lcsh:QH573-671 ,neoplasms ,biology ,business.industry ,lcsh:Cytology ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Primary tumor ,digestive system diseases ,030104 developmental biology ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Immunohistochemistry ,KRAS ,business ,Primary Research - Abstract
Background: No data is available on the molecular background of the extra-nodal extension (ENE) of lymph node metastasis (LN) in colorectal cancer (CRC). Methods: A series of 22 ENE-positive CRCs was considered and three samples per case were selected (the primary CRC, an ENE-negative and an ENE-positive metastatic LN). Samples (n=66) were analysed by immunohistochemistry for PD-L1, CD4, CD8, CD68 and CD80. Fifteen out of twenty-two cases were further profiled through a hotspot multigene mutational custom panel, including 164 hotspot regions of AKT1, APC, BRAF, CTNNB1, KIT, KRAS, NRAS, PDGFRA, PIK3CA, PTEN and TP53 genes. Results: A significantly higher percentage of CD4-, CD8- and CD68-positive cells was observed at the invasive front of both CRCs and in ENE in contrast with what observed at the core of both CRCs and their matched nodal metastases. ENE was also characterized by a significantly higher number of CD80-positive cells. No significant difference was observed in PD-L1 distribution among the different specimens. Fourteen out of 15 CRCs (93%) showed at least a driver mutation. The most frequently mutated gene was TP53 (n=8 tumors), followed by APC (n=6), BRAF (n=4), KRAS, NRAS and PIK3CA (n=2). In 11 out of 15 CRCs (73%) the mutational profiling of the primary tumor was consistent with what obtained from the two matched LNs. Conclusions: A heterogeneous intratumor immune-microenvironment has been observed in ENE-positive CRCs, which are characterized by an increased leukocytic infiltration at the ENE invasive front. © 2018 The Author(s).
- Published
- 2018
38. Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis
- Author
-
Rocco Cappellesso, Paolo Dabrilli, Ambrogio Fassina, Nicola Veronese, Claudio Luchini, Lorenzo Nicolè, Tiziana Sanavia, Nicolè, L., Sanavia, T., Veronese, N., Cappellesso, R., Luchini, C., Dabrilli, P., and Fassina, A.
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Pediatrics ,medicine.medical_treatment ,Disease ,Targeted therapy ,SALL4 ,cancer ,meta-analysis ,prognosis ,targeted therapy ,Humans ,Neoplasms ,Prognosis ,Transcription Factors ,Cancer ,Meta-analysis ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,SALL4, cancer, prognosis, meta-analysis, targeted therapy ,business.industry ,Confounding ,Hazard ratio ,Confidence interval ,eye diseases ,3. Good health ,030104 developmental biology ,030220 oncology & carcinogenesis ,Relative risk ,business ,Research Paper - Abstract
The Spalt-Like Transcription Factor 4 (SALL4) oncogene plays a central function in embryo-fetal development and is absent in differentiated tissues. Evidence suggests that it can be reactivated in several cancers worsening the prognosis. We aimed at investigating the risk associated with SALL4 reactivation for all-cause mortality and recurrence in cancer using the current literature. A PubMed and SCOPUS search until 1st September 2016 was performed, focusing on perspective studies reporting prognostic parameters in cancer data. In addition, 17 datasets of different cancer types from The Cancer Genome Atlas were considered. A total of 9,947 participants across 40 cohorts, followed-up for about 5 years on average, were analyzed comparing patients showing SALL4 presence (SALL4+, n = 1,811) or absence (SALL4-, n = 8,136). All data were summarised using risk ratios (RRs) for the number of deaths/recurrences and hazard ratios (HRs) for the time-dependent risk related to SALL4+, adjusted for potential confounders. SALL4+ significantly increased overall mortality (RR = 1.34, 95% confidence intervals (CI) = 1.21-1.48, p < 0.0001, I2=66%; HR = 1.4; 95%CI: 1.19- 1.65; p < 0.0001; I2=63%) and recurrence of disease (RR = 1.25, 95% CI = 1.1-1.42, p = 0.0006, I2=62%); HR=1.52; 95% CI: 1.22-1.89, p = 0.0002; I2=69%) compared to SALL4-. Moreover, SALL4 remained significantly associated with poor prognosis even using HRs adjusted for potential confounders (overall mortality: HR = 1.4; 95%CI: 1.19-1.65; p < 0.0001; I2=63%; recurrence of disease: HR = 1.52; 95% CI: 1.22-1.89, p = 0.0002; I2=69%). These results suggest that SALL4 expression increases both mortality and recurrence of cancer, confirming this gene as an important prognostic marker and a potential target for personalized medicine.
- Published
- 2017
39. Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis
- Author
-
Rocco Cappellesso, Franca De Lazzari, Pierluigi Pilati, E. Rosa-Rizzotto, Claudio Luchini, Nicola Veronese, Marcello Lo Mele, Marco Solmi, Massimo Rugge, E. Guido, Stefano Realdon, Fabio Farinati, Matteo Fassan, Cappellesso, R., Luchini, C., Veronese, N., Lo Mele, M., Rosa-Rizzotto, E., Guido, E., De Lazzari, F., Pilati, P., Farinati, F., Realdon, S., Solmi, M., Fassan, M., and Rugge, M.
- Subjects
Oncology ,medicine.medical_specialty ,Colorectal cancer ,Biopsy ,Tumor budding ,Adenocarcinoma ,Risk Assessment ,Pathology and Forensic Medicine ,Lymph node metastasis ,Meta-analysis ,Sprouting ,Colorectal Neoplasms ,Humans ,Lymph Nodes ,Lymphatic Metastasis ,Neoplasm Invasiveness ,Neoplasm Staging ,Odds Ratio ,Predictive Value of Tests ,Risk Factors ,Cell Movement ,Lymph node metastasi ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Meta-analysi ,Risk factor ,medicine.diagnostic_test ,business.industry ,Cancer ,Odds ratio ,medicine.disease ,Surgery ,030220 oncology & carcinogenesis ,Predictive value of tests ,030211 gastroenterology & hepatology ,business - Abstract
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the detection of submucosal (pT1) adenocarcinoma. Completion surgery may be indicated after endoscopic excision of these potentially metastasizing early cancers. However, the postsurgical prevalence of nodal implants does not exceed 15%, leading to questions concerning the clinical appropriateness of any post–endoscopy surgery. Eastern scientific societies (Japanese Society for Cancer of the Colon-Rectum, in particular) include tumor budding (TB), defined as the presence of isolated single cancer cells or clusters of fewer than 5 cancer cells at the tumor invasive front, among the variables that must be included in histologic reports. In Western countries, however, no authoritative endorsements recommend the inclusion of TB in the histology report because of the heterogeneity of definitions and measurement methods as well as its apparent poor reproducibility. To assess the prognostic value of TB in pT1 CRCs, this meta-analysis evaluated 41 studies involving a total of 10137 patients. We observed a strong association between the presence of TB and risk of nodal metastasis in pT1 CRC. In comparing TB-positive (684/2401; 28.5%) versus TB-negative (557/7736; 7.2%) patients, the prevalence of nodal disease resulted in an odds ratio value of 6.44 (95% confidence interval, 5.26-7.87; P 
- Published
- 2017
40. Stemness and hybrid epithelial-mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritonei.
- Author
-
Lazzari N, Rigotto G, Montini B, Del Bianco P, Moretto E, Palladino F, Cappellesso R, Tonello M, Cenzi C, Scapinello A, Piano MA, Rossi CR, Dalerba P, Pilati P, Sommariva A, and Calabrò ML
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Aldehyde Dehydrogenase 1 Family metabolism, Aldehyde Dehydrogenase 1 Family genetics, Mesothelioma pathology, Mesothelioma genetics, Prognosis, Lung Neoplasms pathology, Lung Neoplasms genetics, Hyperthermic Intraperitoneal Chemotherapy, Tumor Cells, Cultured, Retinal Dehydrogenase metabolism, Retinal Dehydrogenase genetics, Adult, Peritoneal Neoplasms secondary, Peritoneal Neoplasms pathology, Epithelial-Mesenchymal Transition, Neoplastic Stem Cells pathology, Neoplastic Stem Cells metabolism, Mesothelioma, Malignant pathology, Pseudomyxoma Peritonei pathology, Pseudomyxoma Peritonei metabolism
- Abstract
Intrabdominal dissemination of malignant mesothelioma (MM) and pseudomyxoma peritonei (PMP) is poorly characterized with respect to the stemness window which malignant cells activate during their reshaping on the epithelial-mesenchymal (E/M) axis. To gain insights into stemness properties and their prognostic significance in these rarer forms of peritoneal metastases (PM), primary tumor cultures from 55 patients selected for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy were analyzed for cancer stem cells (CSC) by aldehyde dehydrogenase 1 (ALDH1) and spheroid formation assays, and for expression of a set of plasticity-related genes to measure E/M transition (EMT) score. Intratumor heterogeneity was also analyzed. Samples from PM of colorectal cancer were included for comparison. Molecular data were confirmed using principal component and cluster analyses. Associations with survival were evaluated using Kaplan-Meier and Cox regression models. The activity of acetylsalicylic acid (ASA), a stemness modifier, was tested in five cultures. Significantly increased amounts of ALDH1
bright -cells identified high-grade PMP, and discriminated solid masses from ascitic/mucin-embedded tumor cells in both forms of PM. Epithelial/early hybrid EMT scores and an early hybrid expression pattern correlated with pluripotency factors were significantly associated with early peritoneal progression (p = .0343 and p = .0339, respectively, log-rank test) in multivariable models. ASA impaired spheroid formation and increased cisplatin sensitivity in all five cultures. These data suggest that CSC subpopulations and hybrid E/M states may guide peritoneal spread of MM and PMP. Stemness could be exploited as targetable vulnerability to increase chemosensitivity and improve patient outcomes. Additional research is needed to confirm these preliminary data., (© 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.)- Published
- 2025
- Full Text
- View/download PDF
41. Sentinel Lymph Node Biopsy in Atypical Spitz Tumor: A Systematic Review.
- Author
-
Mazza M, Cavallin F, Galasso E, Del Fiore P, Cappellesso R, Cassalia F, Tropea S, Russo I, Alaibac M, and Mocellin S
- Abstract
Background: Atypical Spitz tumor (AST) is an intermediate category among Spitz melanocytic neoplasms. Sentinel node biopsy (SNB) has been proposed in the clinical management of AST patients, but this approach remains the subject of debate. This systematic review aims to summarize the available evidence on SNB procedures in AST patients., Methods: A comprehensive search was conducted, including MEDLINE/Pubmed, EMBASE, and SCOPUS, through April 2023. Case series, cohort studies, and case-control studies of AST patients were eligible for inclusion. PRISMA guidelines were followed., Results: Twenty-two studies with a total of 756 AST patients were included. The pooled SNB prevalence was 54% (95% CI 32 to 75%), with substantial heterogeneity (I2 90%). The pooled SNB+ prevalence was 35% (95% CI 25 to 46%) with moderate heterogeneity (I2 39%). Lymphadenectomy was performed in 0-100% of SNB+ patients. Overall survival rates ranged from 93% to 100%, and disease-free survival ranged from 87% to 100% in AST patients. Overall and disease-free survival rates were 100% in SNB patients. Pooled survival estimates were not calculated due to the heterogeneous timing of the survival assessment and/or the small size of the subgroups. All studies clearly reported inclusion criteria and measured the condition in a standard way for all participants, but only 50% indicated valid methods for the identification of the condition., Conclusions: The oncologic behavior of AST is related to an almost always favorable outcome. SNB does not seem to be relevant as a staging or prognostic procedure, and its indication remains debatable and controversial.
- Published
- 2024
- Full Text
- View/download PDF
42. SlideTiler: A dataset creator software for boosting deep learning on histological whole slide images.
- Author
-
Barcellona L, Nicolè L, Cappellesso R, Dei Tos AP, and Ghidoni S
- Abstract
The introduction of deep learning caused a significant breakthrough in digital pathology. Thanks to its capability of mining hidden data patterns in digitised histological slides to resolve diagnostic tasks and extract prognostic and predictive information. However, the high performance achieved in classification tasks depends on the availability of large datasets, whose collection and preprocessing are still time-consuming processes. Therefore, strategies to make these steps more efficient are worth investigation. This work introduces SlideTiler, an open-source software with a user-friendly graphical interface. SlideTiler can manage several image preprocessing phases through an intuitive workflow that does not require specific coding skills. The software was designed to provide direct access to virtual slides, allowing custom tiling of specific regions of interest drawn by the user, tile labelling, quality assessment, and direct export to dataset directories. To illustrate the functions and the scalability of SlideTiler, a deep learning-based classifier was implemented to classify 4 different tumour histotypes available in the TCGA repository. The results demonstrate the effectiveness of SlideTiler in facilitating data preprocessing and promoting accessibility to digitised pathology images for research purposes. Considering the increasing interest in deep learning applications of digital pathology, SlideTiler has a positive impact on this field. Moreover, SlideTiler has been conceived as a dynamic tool in constant evolution, and more updated and efficient versions will be released in the future., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The following are the supplementary data related to this article. Supplementary video 1Supplementary video 1 Supplementary data to this article can be found online at https://doi.org/10.1016/j.jpi.2023.100356., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
43. Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis.
- Author
-
Hench J, Mihic-Probst D, Agaimy A, Frank S, Meyer P, Hultschig C, Simi S, Alos L, Balamurugan T, Blokx W, Bosisio F, Cappellesso R, Griewank K, Hadaschik E, van Kempen LC, Kempf W, Lentini M, Mazzucchelli L, Rinaldi G, Rutkowski P, Schadendorf D, Schilling B, Szumera-Cieckiewicz A, van den Oord J, Mandalà M, and Massi D
- Subjects
- Humans, Retrospective Studies, Skin Neoplasms genetics, Skin Neoplasms pathology, Melanoma pathology, Sarcoma diagnosis, Soft Tissue Neoplasms
- Abstract
Purpose: Dedifferentiated melanoma (DedM) poses significant diagnostic challenges. We aimed to investigate the clinical, histopathological and molecular features of DedM. Methylation signature (MS) and copy number profiling (CNP) were carried out in a subgroup of cases., Patients and Methods: A retrospective series of 78 DedM tissue samples from 61 patients retrieved from EORTC (European Organisation for Research and Treatment of Cancer) Melanoma Group centres were centrally reviewed. Clinical and histopathological features were retrieved. In a subgroup of patients, genotyping through Infinium Methylation microarray and CNP analysis was carried out., Results: Most patients (60/61) had a metastatic DedM showing most frequently an unclassified pleomorphic, spindle cell, or small round cell morphology akin to undifferentiated soft tissue sarcoma, rarely associated with heterologous elements. Overall, among 20 successfully analysed tissue samples from 16 patients, we found retained melanoma-like MS in only 7 tissue samples while a non-melanoma-like MS was observed in 13 tissue samples. In two patients from whom multiple specimens were analysed, some of the samples had a preserved cutaneous melanoma MS while other specimens exhibited an epigenetic shift towards a mesenchymal/sarcoma-like profile, matching the histological features. In these two patients, CNP was largely identical across all analysed specimens, in line with their common clonal origin, despite significant modification of their epigenome., Conclusions: Our study further highlights that DedM represents a real diagnostic challenge. While MS and genomic CNP may help pathologists to diagnose DedM, we provide proof-of-concept that dedifferentiation in melanoma is frequently associated with epigenetic modifications., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
44. Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features.
- Author
-
Del Fiore P, Cavallin F, Mazza M, Benna C, Monico AD, Tadiotto G, Russo I, Ferrazzi B, Tropea S, Buja A, Cozzolino C, Cappellesso R, Nicolè L, Piccin L, Pigozzo J, Chiarion-Sileni V, Vecchiato A, Menin C, Bassetto F, Dei Tos AP, Alaibac M, and Mocellin S
- Subjects
- Humans, Retrospective Studies, Italy epidemiology, Melanoma epidemiology
- Abstract
Per- and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals which could be associated with cancer development, such as kidney and testicular cancers, pancreatic and hepatocellular carcinoma and thyroid tumor. Available scientific literature offers no information on the role of PFAS in melanoma development/progression. Since 1965, a massive environmental contamination by PFAS has occurred in northeastern Italy. This study compared histopathology and prognosis between melanoma patients exposed (n = 194) and unexposed (n = 488) to PFAS. All patients were diagnosed and/or treated for melanoma at the Veneto Oncological Institute and the University Hospital of Padua (Italy) in 1998-2014. Patients were categorized in exposed or unexposed groups according to their home address and the geographical classification of municipalities affected by PFAS contamination as provided by Veneto Government in 2018. Presence of mitoses was found in 70.5% of exposed patients and 58.7% of unexposed patients (p = 0.005). Median follow-up was 90 months (IQR 59-136). 5-year overall survival was 83.7% in exposed patients and 88.0% in unexposed patients (p = 0.20); 5-year disease-specific survival was 88.0% in exposed patients and 90.9% in unexposed patients (p = 0.50); 5-year disease-free survival was 83.8% in exposed patients and 87.3% in unexposed patients (p = 0.20). Adjusting for imbalanced characteristics at baseline (presence of mitoses), survival was not statistically different between exposed and unexposed patients (overall survival: HR 1.10, 95% CI 0.77 to 1.58, p = 0.57; disease-specific survival: HR 0.99, 95% CI 0.62 to 1.59, p = 0.99; disease-free survival: HR 1.10, 95% CI 0.74 to 1.64, p = 0.62). Although the magnitude of PFAS exposure was not quantifiable, our findings suggested that exposure to PFAS was associated with higher level of mitosis in melanoma patients, but this did not translate into a survival difference. Further studies are required to investigate this relationship and all effects of PFAS on prognosis., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
45. TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions.
- Author
-
Cappellesso R, Nicolè L, Del Fiore P, Barzon L, Sinigaglia A, Riccetti S, Franco R, Zito Marino F, Munari G, Zamuner C, Cavallin F, Sbaraglia M, Galuppini F, Bassetto F, Alaibac M, Chiarion-Sileni V, Piccin L, Benna C, Fassan M, Mocellin S, and Dei Tos AP
- Subjects
- Humans, Receptor, trkA genetics, Nerve Growth Factors therapeutic use, Receptor, trkC genetics, Oncogene Proteins, Fusion genetics, Biomarkers, Tumor genetics, Carcinoma, Merkel Cell genetics, Neoplasms pathology, Skin Neoplasms genetics
- Abstract
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignant tumor with neuroendocrine differentiation, with a rapidly growing incidence rate, high risk of recurrence, and aggressive behavior. The available therapeutic options for advanced disease are limited and there is a pressing need for new treatments. Tumors harboring fusions involving one of the neurotrophin receptor tyrosine kinase ( NTRK ) genes are now actionable with targeted inhibitors. NTRK -fused genes have been identified in neuroendocrine tumors of other sites; thus, a series of 76 MCCs were firstly analyzed with pan-TRK immunohistochemistry and the positive ones with real-time RT-PCR, RNA-based NGS, and FISH to detect the eventual underlying gene fusion. Despite 34 MCCs showing pan-TRK expression, NTRK fusions were not found in any cases. As in other tumors with neural differentiation, TRK expression seems to be physiological and not caused by gene fusions.
- Published
- 2022
- Full Text
- View/download PDF
46. Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study.
- Author
-
Del Fiore P, Russo I, Dal Monico A, Tartaglia J, Ferrazzi B, Mazza M, Cavallin F, Tropea S, Buja A, Cappellesso R, Nicolè L, Chiarion-Sileni V, Menin C, Vecchiato A, Dei Tos AP, Alaibac M, and Mocellin S
- Abstract
The incidence of cutaneous melanoma has been increasing in the last decades among the fair-skinned population. Despite its complex and multifactorial etiology, the exposure to ultraviolet radiation (UVR) is the most consistent modifiable risk factor for melanoma. Several factors influence the amount of UVR reaching the Earth's surface. Our study aimed to explore the relationship between melanoma and altitude in an area with mixed geographic morphology, such as the Veneto region (Italy). We included 2752 melanoma patients who were referred to our centers between 1998 and 2014. Demographics, histological and clinical data, and survival information were extracted from a prospectively maintained local database. Head/neck and acral melanoma were more common in patients from the hills and the mountains, while limb and trunk melanoma were more common in patients living in plain and coastal areas. Breslow thickness, ulceration and mitotic rate impaired with increased altitude. However, the geographical area of origin was not associated with overall or disease-free survival. The geographical area of origin of melanoma patients and the "coast-plain-hill gradient" could help to estimate the influence of different sun exposure and to explain the importance of vitamin D levels in skin-cancer control.
- Published
- 2022
- Full Text
- View/download PDF
47. Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series.
- Author
-
Zarrilli G, Angerilli V, Cappellesso R, Galuppini F, Pennelli G, Farinati F, Nicolè L, Savarino E, Realdon S, Griguolo G, Bottosso M, Dieci MV, Guarneri V, Dei Tos AP, Lo Mele M, and Fassan M
- Subjects
- Estrogens, Female, Humans, Keratin-7, Retrospective Studies, Stomach, Breast Neoplasms
- Abstract
The metastatic spread of breast carcinoma to the stomach is a rare event and often represents a diagnostic challenge. In the present study, 23 cases of gastric metastases from breast cancer were retrospectively identified dating back until 2007. Primitive histotype, localization, gross appearance, microscopic architecture were analyzed. Cytokeratins 7 and 20, sex hormones, HER2 and Ki67 expression was evaluated. According to the results, the series was characterized by an enrichment of lobular primitive histotype (43.7%). In most cases gastric metastases were described as parietal nodules, polypoid masses or ulcerated lesions, mainly involving the antro-angular region. In a relatively high rate (10.5%) of cases, endoscopic examinations resulted negative for macroscopic lesions. More than half of the cases (52.2%) microscopically resembled primitive poorly cohesive gastric cancer. Because gross and histological findings can be deceiving, immunohistochemistry may be essential for the diagnosis of gastric metastases from breast cancer. Accordingly with the results of our analysis and literature review, an immunohistochemical panel composed of cytokeratins 7 and 20, Estrogen and Progesteron Receptors would drastically improve diagnostic accuracy. Interaction among the clinician, endoscopist and the pathologist is also essential to provide the patient the best therapeutic option., (Copyright © 2022 Elsevier GmbH. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
48. The Morpho-Molecular Landscape of Spitz Neoplasms.
- Author
-
Dal Pozzo CA and Cappellesso R
- Subjects
- Humans, Mutation, Receptor Protein-Tyrosine Kinases genetics, Melanoma genetics, Melanoma pathology, Nevus, Epithelioid and Spindle Cell diagnosis, Nevus, Epithelioid and Spindle Cell genetics, Skin Neoplasms diagnosis, Skin Neoplasms genetics, Skin Neoplasms pathology
- Abstract
Spitz neoplasms are a heterogeneous group of melanocytic proliferations with a great variability in the histological characteristics and in the biological behavior. Thanks to recent discoveries, the morpho-molecular landscape of Spitz lineage is becoming clearer, with the identification of subtypes with recurrent features thus providing the basis for a more solid and precise tumor classification. Indeed, specific mutually exclusive driver molecular events, namely HRAS or MAP2K1 mutations, copy number gains of 11p, and fusions involving ALK, ROS, NTRK1, NTRK2, NTRK3, MET, RET, MAP3K8, and BRAF genes, correlate with distinctive histological features. The accumulation of further molecular aberrations, instead, promotes the increasing malignant transformation of Spitz neoplasms. Thus, the detection of a driver genetic alteration can be achieved using the appropriate diagnostic tests chosen according to the histological characteristics of the lesion. This allows the recognition of subtypes with aggressive behavior requiring further molecular investigations. This review provides an update on the morpho-molecular correlations in Spitz neoplasms.
- Published
- 2022
- Full Text
- View/download PDF
49. Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3 + and CD8 + T cell density and predict prognosis in hepatocellular carcinoma.
- Author
-
Nicolè L, Sanavia T, Cappellesso R, Maffeis V, Akiba J, Kawahara A, Naito Y, Radu CM, Simioni P, Serafin D, Cortese G, Guido M, Zanus G, Yano H, and Fassina A
- Subjects
- CD8-Positive T-Lymphocytes metabolism, Cell Count, Humans, Necroptosis genetics, Prognosis, Protein Kinases genetics, Protein Kinases metabolism, Receptor-Interacting Protein Serine-Threonine Kinases genetics, Receptor-Interacting Protein Serine-Threonine Kinases metabolism, Carcinoma, Hepatocellular genetics, Liver Neoplasms genetics
- Abstract
Background: Hepatocellular carcinoma (HCC) is a highly lethal cancer and the second leading cause of cancer-related deaths worldwide. As demonstrated in other solid neoplasms and HCC, infiltrating CD8
+ T cells seem to be related to a better prognosis, but the mechanisms affecting the immune landscape in HCC are still mostly unknown. Necroptosis is a programmed, caspase-independent cell death that, unlike apoptosis, evokes immune response by releasing damage-associated molecular factors. However, in HCC, the relationship between the necroptotic machinery and the tumor-infiltrating lymphocytes has not been fully investigated so far., Methods: We investigated the association between the main necroptosis-related genes, that is, RIPK1 , RIPK3, MLKL-p , and CD3+ /CD8+ tumor-infiltrating T cell by RNA-seq data analysis in 371 patients with primary HCC from The Cancer Genome Atlas and then by immunohistochemistry in two independent cohorts of HCC patients from Italy (82) and Japan (86)., Results: Our findings highlighted the immunogenetic role of necroptosis and its potential prognostic role in HCC: RIPK1, RIPK3 and MLKL-p were found significantly associated with intratumoral CD3+ and CD8+ T cells. In addition, multivariate survival analysis showed that the expression of RIPK1, RIPK3 and MLKL-p was associated with better overall survival in the two independent cohorts., Conclusions: Our results confirmed the immunogenetic properties of necroptosis (NCP) in human HCC, showing that tumor-infiltrating lymphocytes (TILs) and, specifically, CD8+ T cells accumulate in tumors with higher expression of the necroptosis-related genes. These results suggest the importance of further studies to better assess the specific composition, as well as the functional features of the immune environment associated with a necroptotic signature in order to explore new possible diagnostic and immunotherapeutic scenarios., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2022
- Full Text
- View/download PDF
50. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
- Author
-
Cappellesso R, Nozzoli F, Zito Marino F, Simi S, Castiglione F, De Giorgi V, Cota C, Senetta R, Scognamiglio G, Anniciello AM, Cesinaro AM, Mandalà M, Gianatti A, Valente MG, Valeri B, Sementa AR, Ricci C, Corti B, Roviello G, Dei Tos AP, Franco R, and Massi D
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Data Accuracy, Female, High-Throughput Nucleotide Sequencing methods, Humans, Immunohistochemistry methods, In Situ Hybridization, Fluorescence methods, Male, Middle Aged, Oncogene Proteins, Fusion genetics, Oncogene Proteins, Fusion metabolism, Real-Time Polymerase Chain Reaction methods, Sequence Analysis, RNA methods, Young Adult, Nevus, Epithelioid and Spindle Cell genetics, Nevus, Epithelioid and Spindle Cell metabolism, Oncogene Fusion, Receptor, trkA genetics, Receptor, trkA metabolism, Receptor, trkC genetics, Receptor, trkC metabolism, Skin Neoplasms genetics, Skin Neoplasms metabolism
- Abstract
Atypical Spitz tumors (AST) deviate from stereotypical Spitz nevi for one or more atypical features and are now regarded as an intermediate category of melanocytic tumors with uncertain malignant potential. Activating NTRK1/NTRK3 fusions elicit oncogenic events in Spitz lesions and are targetable with kinase inhibitors. However, their prevalence among ASTs and the optimal approach for their detection is yet to be determined. A series of 180 ASTs were screened with pan-TRK immunohistochemistry and the presence of NTRK fusions was confirmed using FISH, two different RNA-based NGS panels for solid tumors, and a specific real time RT-PCR panel. Overall, 26 ASTs showed pan-TRK immunostaining. NTRK1 fusions were detected in 15 of these cases showing cytoplasmic immunoreaction, whereas NTRK3 was detected in one case showing nuclear immunoreaction. Molecular tests resulted all positive in only two ASTs (included the NTRK3 translocated), RNA-based NGS and real time RT-PCR were both positive in three cases, and FISH and real time RT-PCR in another two cases. In seven ASTs NTRK1 fusions were detected only by FISH and in two cases only by real time RT-PCR. The frequency of NTRK fusions in ASTs is 9%, with a clear prevalence of NTRK1 compared to NTRK3 alterations. Pan-TRK immunohistochemistry is an excellent screening test. Confirmation of NTRK fusions may require the use of different molecular techniques.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.